These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 23026726)

  • 41. Sporting Activity Is Reduced 11 Years After First-Generation Autologous Chondrocyte Implantation in the Knee Joint.
    Erdle B; Herrmann S; Porichis S; Uhl M; Ghanem N; Schmal H; Suedkamp N; Niemeyer P; Salzmann GM
    Am J Sports Med; 2017 Oct; 45(12):2762-2773. PubMed ID: 28787185
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Focal cartilage defects in the knee - a randomized controlled trial comparing autologous chondrocyte implantation with arthroscopic debridement.
    Randsborg PH; Brinchmann J; Løken S; Hanvold HA; Aae TF; Årøen A
    BMC Musculoskelet Disord; 2016 Mar; 17():117. PubMed ID: 26956476
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term follow-up evaluation of autologous chondrocyte implantation for symptomatic cartilage lesions of the knee: A single-centre prospective study.
    Berruto M; Ferrua P; Pasqualotto S; Uboldi F; Maione A; Tradati D; Usellini E
    Injury; 2017 Oct; 48(10):2230-2234. PubMed ID: 28803652
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autologous Chondrocyte Implantation for Bipolar Chondral Lesions in the Tibiofemoral Compartment.
    Ogura T; Bryant T; Mosier BA; Minas T
    Am J Sports Med; 2018 May; 46(6):1371-1381. PubMed ID: 29533678
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autologous chondrocyte implantation for the treatment of large full-thickness cartilage lesions of the knee.
    Ossendorf C; Kreuz PC; Steinwachs MR; Erggelet C
    Saudi Med J; 2007 Aug; 28(8):1251-6. PubMed ID: 17676213
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture.
    Saris DB; Vanlauwe J; Victor J; Haspl M; Bohnsack M; Fortems Y; Vandekerckhove B; Almqvist KF; Claes T; Handelberg F; Lagae K; van der Bauwhede J; Vandenneucker H; Yang KG; Jelic M; Verdonk R; Veulemans N; Bellemans J; Luyten FP
    Am J Sports Med; 2008 Feb; 36(2):235-46. PubMed ID: 18202295
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autologous chondrocyte implantation and anteromedialization for isolated patellar articular cartilage lesions: 5- to 11-year follow-up.
    Gillogly SD; Arnold RM
    Am J Sports Med; 2014 Apr; 42(4):912-20. PubMed ID: 24519181
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autologous chondrocyte implantation in the knee: mid-term to long-term results.
    Nawaz SZ; Bentley G; Briggs TW; Carrington RW; Skinner JA; Gallagher KR; Dhinsa BS
    J Bone Joint Surg Am; 2014 May; 96(10):824-30. PubMed ID: 24875023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outcomes of autologous chondrocyte implantation in study of the treatment of articular repair (STAR) patients with osteochondritis dissecans.
    Cole BJ; DeBerardino T; Brewster R; Farr J; Levine DW; Nissen C; Roaf P; Zaslav K
    Am J Sports Med; 2012 Sep; 40(9):2015-22. PubMed ID: 22822178
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A 20-Year Follow-up After First-Generation Autologous Chondrocyte Implantation.
    Ogura T; Mosier BA; Bryant T; Minas T
    Am J Sports Med; 2017 Oct; 45(12):2751-2761. PubMed ID: 28745972
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isolated full thickness chondral injuries. Prevalance and outcome of treatment. A retrospective study of 5233 knee arthroscopies.
    Widuchowski W; Lukasik P; Kwiatkowski G; Faltus R; Szyluk K; Widuchowski J; Koczy B
    Acta Chir Orthop Traumatol Cech; 2008 Oct; 75(5):382-6. PubMed ID: 19026193
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of Full-Thickness Chondral Defects With Hyalograft C in the Knee: Long-term Results.
    Brix MO; Stelzeneder D; Chiari C; Koller U; Nehrer S; Dorotka R; Windhager R; Domayer SE
    Am J Sports Med; 2014 Jun; 42(6):1426-32. PubMed ID: 24664138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and radiological long-term outcomes after matrix-induced autologous chondrocyte transplantation: a prospective follow-up at a minimum of 10 years.
    Aldrian S; Zak L; Wondrasch B; Albrecht C; Stelzeneder B; Binder H; Kovar F; Trattnig S; Marlovits S
    Am J Sports Med; 2014 Nov; 42(11):2680-8. PubMed ID: 25204296
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical, radiological, and histological outcomes after the fibrin-matrix autologous chondrocyte implantation for chondral lesions of the knee in patients more than 50 years old: A prospective case series with minimum 2-year follow-up.
    Kim MK; Park JS; Jeon YM; Jeon YS
    J Orthop Surg (Hong Kong); 2020; 28(1):2309499019893509. PubMed ID: 31876240
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Articular cartilage treatment in high-level male soccer players: a prospective comparative study of arthroscopic second-generation autologous chondrocyte implantation versus microfracture.
    Kon E; Filardo G; Berruto M; Benazzo F; Zanon G; Della Villa S; Marcacci M
    Am J Sports Med; 2011 Dec; 39(12):2549-57. PubMed ID: 21900624
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcomes of autologous chondrocyte implantation in a diverse patient population.
    McNickle AG; L'Heureux DR; Yanke AB; Cole BJ
    Am J Sports Med; 2009 Jul; 37(7):1344-50. PubMed ID: 19286911
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterized chondrocyte implantation in the patellofemoral joint: an up to 4-year follow-up of a prospective cohort of 38 patients.
    Vanlauwe JJ; Claes T; Van Assche D; Bellemans J; Luyten FP
    Am J Sports Med; 2012 Aug; 40(8):1799-807. PubMed ID: 22785604
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term clinical results and MRI changes after autologous chondrocyte implantation in the knee of young and active middle aged patients.
    Rosa D; Balato G; Ciaramella G; Soscia E; Improta G; Triassi M
    J Orthop Traumatol; 2016 Mar; 17(1):55-62. PubMed ID: 26496929
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: a prospective, randomised study.
    Bartlett W; Skinner JA; Gooding CR; Carrington RW; Flanagan AM; Briggs TW; Bentley G
    J Bone Joint Surg Br; 2005 May; 87(5):640-5. PubMed ID: 15855365
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Equivalent 10-Year Outcomes After Implantation of Autologous Bone Marrow-Derived Mesenchymal Stem Cells Versus Autologous Chondrocyte Implantation for Chondral Defects of the Knee.
    Teo AQA; Wong KL; Shen L; Lim JY; Toh WS; Lee EH; Hui JHP
    Am J Sports Med; 2019 Oct; 47(12):2881-2887. PubMed ID: 31433674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.